Andrea van Elsas
Direktor/Vorstandsmitglied bei MENDUS AB
Ursprung des Netzwerks ersten Grades von Andrea van Elsas
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.
53
| Private Company | Investment Managers | 53 |
University of Leiden
30
| College/University | Other Consumer Services | 30 |
University of Amsterdam
20
| College/University | Other Consumer Services | 20 |
Extinct | Pharmaceuticals: Major | 18 | |
17
| Public Company | Biotechnology | 17 |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.
16
| Holding Company | Biotechnology | 16 |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer.
12
| Holding Company | Biotechnology | 12 |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.
10
| Holding Company | Biotechnology | 10 |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.
6
| Subsidiary | Medical Specialties | 6 |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Aduro Biotech Holdings Europe BV
Aduro Biotech Holdings Europe BV BiotechnologyHealth Technology Aduro Biotech Holdings Europe BV operates as a biopharmaceutical company specializing in immune oncology antibody discovery. The firm’s technology creates a pipeline of antibodies aiming to treat the immune system of cancer patients. Its antibody portfolio includes immune checkpoint inhibitors and novel antibody formats. The company was founded by Wiebe Olijve, Andrea van Elsas, and Hans van Eenennaam in 2011 and is headquartered in Oss, the Netherlands.
2
| Subsidiary | Biotechnology | 2 |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Organon Pharmaceuticals USA, Inc.
Organon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Organon Pharmaceutical USA, Inc. markets and distributes pharmaceutical products. Its products include contraceptives and anesthetics, as well as treatments for mental health disorders. The company is headquartered in Roseland, NJ.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Andrea van Elsas
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree | |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chairman Chief Operating Officer Corporate Officer/Principal | |
NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Founder | |
CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member President Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member | |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member Consultant / Advisor | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Graduate Degree Masters Business Admin Undergraduate Degree | |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Undergraduate Degree Graduate Degree Doctorate Degree | |
Casma Therapeutics, Inc.
Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Casma Therapeutics, Inc. operates biotechnology company harnessing natural cellular process of autophagy to design new medicines. The company was founded by Cary Pfeffer and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Founder Founder Director/Board Member Founder | |
JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Chief Executive Officer | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Consultant / Advisor | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
FOUNDATION MEDICINE INC | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Executive Officer | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Founder Corporate Officer/Principal | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Stanford University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Radboud University Nijmegen | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Chairman | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Private Equity Investor | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
Yale University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
Septerna, Inc.
Septerna, Inc. Pharmaceuticals: MajorHealth Technology Septerna, Inc. is a biotechnology company located in an undisclosed location. The American company is focused on developing novel, oral small molecule drugs that target the entire class of G protein-coupled receptors (GPCRs). The company's Native Complex™ platform allows for the rapid application of new technologies for industrial-scale drug discovery to address both validated GPCRs and many GPCRs that have been undruggable and unexploited to date. Septerna is building a pipeline of GPCR-targeted, oral small molecule drug candidates, led by its program targeting the parathyroid hormone 1 receptor (PTH1R) for the treatment of hypoparathyroidism. The company was founded in 2022 by scientific founders who have made groundbreaking GPCR discoveries, including Patrick Sexton, Arthur Christopoulos, Robert Joseph Lefkowitz, and Jeffrey T. Finer. Jeffrey T. Finer has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman Founder Chief Operating Officer | |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Chief Operating Officer | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
TANGO THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
Brandeis University | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Third Rock Ventures GP LP | Founder Corporate Officer/Principal | ||
SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chief Executive Officer Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 46 |
Niederlande | 4 |
Schweiz | 2 |
Frankreich | 2 |
Sektoral
Health Technology | 27 |
Consumer Services | 13 |
Commercial Services | 7 |
Health Services | 4 |
Finance | 3 |
Operativ
Director/Board Member | 465 |
Corporate Officer/Principal | 253 |
Independent Dir/Board Member | 113 |
Chief Executive Officer | 87 |
Chairman | 74 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Raphaël Wisniewski | 45 |
Lok Chung Chan | 40 |
Steven Paul | 38 |
Neil Exter | 33 |
Martijn Kleijwegt | 33 |
Rémi Droller | 29 |
Charles Homcy | 28 |
Mitchell Finer | 26 |
Stephen Sherwin | 26 |
Mark Levin | 26 |
Dharminder Singh Chahal | 25 |
Alexis Borisy | 25 |
Mary Lynne Hedley | 25 |
Sven Arne Andréasson | 24 |
Robert Tepper | 24 |
- Börse
- Insiders
- Andrea van Elsas
- Unternehmensverbindungen